These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 10829155)

  • 1. Converting from oral morphine to subcutaneous diamorphine.
    Amesbury B
    Palliat Med; 2000 Mar; 14(2):165-7. PubMed ID: 10829155
    [No Abstract]   [Full Text] [Related]  

  • 2. Intranasal diamorphine as an alternative to intramuscular morphine: pharmacokinetic and pharmacodynamic aspects.
    Kendall JM; Latter VS
    Clin Pharmacokinet; 2003; 42(6):501-13. PubMed ID: 12793836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The equipotent dose ratio of diamorphine and morphine administered by mouth.
    Twycross RG
    Br J Pharmacol; 1972 Nov; 46(3):554P-555P. PubMed ID: 4120846
    [No Abstract]   [Full Text] [Related]  

  • 4. Opioid use in palliative care of children and young people with cancer.
    Hewitt M; Goldman A; Collins GS; Childs M; Hain R
    J Pediatr; 2008 Jan; 152(1):39-44. PubMed ID: 18154896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Morphine and alternative opioids in cancer pain: the EAPC recommendations.
    Hanks GW; Conno F; Cherny N; Hanna M; Kalso E; McQuay HJ; Mercadante S; Meynadier J; Poulain P; Ripamonti C; Radbruch L; Casas JR; Sawe J; Twycross RG; Ventafridda V;
    Br J Cancer; 2001 Mar; 84(5):587-93. PubMed ID: 11237376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Towards evidence based emergency medicine: best BETs from the Manchester Royal Infirmary. BET 1: intranasal fentanyl or diamorphine versus intravenous morphine for analgesia in adults.
    Helliwell L; Jackson C
    Emerg Med J; 2010 Sep; 27(9):715-6. PubMed ID: 20798100
    [No Abstract]   [Full Text] [Related]  

  • 7. Opioid medication in the palliative care of motor neurone disease.
    Oliver D
    Palliat Med; 1998 Mar; 12(2):113-5. PubMed ID: 9616447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. National survey of drug use in palliative care.
    Drummond SH; Peterson GM; Galloway JG; Keefe PA
    Palliat Med; 1996 Apr; 10(2):119-24. PubMed ID: 8800819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ulcerative skin reaction from subcutaneous infusion of isotonic methotrimeprazine and diamorphine.
    Hatton MQ; McMurray A; Harnett AN
    Clin Oncol (R Coll Radiol); 1995; 7(4):268-9. PubMed ID: 8845330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of morphine concentration-time profiles following intravenous and intranasal diamorphine in children.
    Kidd S; Brennan S; Stephen R; Minns R; Beattie T
    Arch Dis Child; 2009 Dec; 94(12):974-8. PubMed ID: 19793724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Choice of strong analgesic in terminal cancer: diamorphine or morphine?
    Twycross RG
    Pain; 1977 Apr; 3(2):93-104. PubMed ID: 69290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intranasal diamorphine for acute sickle cell pain.
    Telfer P; Criddle J; Sandell J; Davies F; Morrison I; Challands J
    Arch Dis Child; 2009 Dec; 94(12):979-80. PubMed ID: 19321506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intranasal diamorphine for paediatric analgesia: assessment of safety and efficacy.
    Wilson JA; Kendall JM; Cornelius P
    J Accid Emerg Med; 1997 Mar; 14(2):70-2. PubMed ID: 9132194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The therapeutic equivalence of oral and subcutaneous/intramuscular morphine sulphate in cancer patients.
    Twycross RG
    J Palliat Care; 1988 May; 4(1-2):67-8. PubMed ID: 2459361
    [No Abstract]   [Full Text] [Related]  

  • 15. Topical morphine for cutaneous cancer pain.
    Krajnik M; Zylicz Z
    Palliat Med; 1997 Jul; 11(4):325. PubMed ID: 9373587
    [No Abstract]   [Full Text] [Related]  

  • 16. Oral diacetylmorphine (heroin) yields greater morphine bioavailability than oral morphine: bioavailability related to dosage and prior opioid exposure.
    Halbsguth U; Rentsch KM; Eich-Höchli D; Diterich I; Fattinger K
    Br J Clin Pharmacol; 2008 Dec; 66(6):781-91. PubMed ID: 18945270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methadone as an additional opioid for a cancer patient with severe neuropathic and bone pain not responsive to other opioids and adjuvant analgesics.
    Leppert W; Kowalski G
    J Palliat Care; 2013; 29(2):119-21. PubMed ID: 23923476
    [No Abstract]   [Full Text] [Related]  

  • 18. Parenteral morphine prescribing patterns among inpatients with pain from advanced cancer: a prospective survey of intravenous and subcutaneous use.
    Walsh D; Perin ML; McIver B
    Am J Hosp Palliat Care; 2006; 23(5):353-9. PubMed ID: 17060302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased local toxicity with subcutaneous diamorphine (heroin): a preliminary report.
    Bruera E; Macmillan K; Selmser P; MacDonald NR
    Pain; 1990 Oct; 43(1):91-94. PubMed ID: 1703651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Continuous subcutaneous infusion in palliative care, an undervalued method].
    Keijer WJ; de Jong RJ
    Ned Tijdschr Geneeskd; 2003 Feb; 147(7):318-9; author reply 319. PubMed ID: 12622011
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.